Cytomedix Inc. (OTC: CMXI), a biotechnology company focused on the development of regenerative therapies to primarily address the areas of wound care, inflammation and angiogenesis, has seen a sharp rise in its shares in trading today.
Cytomedix Inc. (OTC: CMXI), a biotechnology company focused on the development of regenerative therapies to primarily address the areas of wound care, inflammation and angiogenesis, has seen a sharp rise in its shares in trading today.